(106 days)
DePuy Synthes Tibial Nail Advanced System:
The Tibial Nail Advanced implants are intended for treatment of fractures in adolescents (12-21) in which the growth plates have fused. Specifically, the implants are indicated for:
- · Open and closed proximal and distal tibial fractures
- Open and closed tibial shaft fractures
- · Tibial malunions and nonunions
DePuy Synthes Locking Screws for Medullary Nails, 4.0 and 5.0 mm:
DePuy Synthes Locking Screws are used for the static and dynamic interlocking of femoral, humeral and tibial nails.
DePuy Synthes Tibial Nail Advanced System:
The DePuy Synthes Tibial Nail Advanced System is a system comprised of intramedullary nails, locking screws, end caps implants, as well as system-specific insertion instruments. The Tibial Nail Advanced System is intended to be used for temporary fixation and stabilization of tibia. This system enables three different surgical approaches for the insertion of the nailing implant in the tibia: suprapatellar. parapatellar, and infrapatellar. The implants are manufactured from titanium alloys and provided in a range of dimensions to match individual patient anatomy. The intramedullary nailing implants are cannulated and can be inserted over a reaming rod. The nailing implants are offered in a range of proximal and distal shaft diameters and lengths to accommodate patient anatomy and surgical need related to the specific fracture patterns and locations. The nails will be manufactured from titanium alloy (Ti-6Al-4V) and polyetherketone (PEEK).
DePuy Synthes Locking Screws for Medullary Nails, 4.0 and 5.0 mm:
The DePuy Synthes Locking Screws for Medullary Nails, 4.0 and 5.0 mm have a diameter of 5 mm available in lengths ranging from 26 up to 120 mm and a diameter of 4 mm available in lengths ranging from 18 up to 80 mm. These implantable devices are fully threaded at the shaft and are self-tapping. The locking screws feature either a standard screw head or a low-profile screw head. The screws are made from titanium alloy (Ti-6Al-7Nb).
This appears to be a 510(k) summary for a medical device (DePuy Synthes Tibial Nail Advanced System and Locking Screws). These submissions typically focus on demonstrating substantial equivalence to a predicate device rather than presenting detailed studies with specific acceptance criteria, sample sizes, and expert adjudication for AI/software performance.
Therefore, the requested information regarding AI/software performance studies, acceptance criteria, sample sizes for test/training sets, expert ground truth establishment, adjudication methods, and MRMC studies is not present in the provided document.
This document describes a traditional medical device (implants and screws for bone fixation) and its non-clinical performance data (mechanical testing, biocompatibility, MRI safety), comparing it to predicate devices. There is no mention of any AI or software component in this device.
Table of Acceptance Criteria and Reported Device Performance:
Since this document describes a physical medical device (implants and screws) and not an AI/software device, the acceptance criteria and performance are based on non-clinical tests comparing it to predicate devices. The document states that the new device is "substantially equivalent" to predicate devices, meaning it performs at least as safely and effectively.
| Acceptance Criteria Category | Specific Test/Evaluation | Reported Device Performance |
|---|---|---|
| Biocompatibility | LAL testing per FDA guidance "Submission and Review of Sterility Information..." | Meets 20 EU/device limit when sterilized by gamma radiation. |
| Biocompatibility assessment per FDA guidance "Use of International Standard ISO 10993-1..." | Assessment supports safety according to the standard. | |
| Mechanical Strength (Tibial Nail System) | Proximal and distal locking static torsion test (according to ASTM F1264-16 A2.1.7). | Performance supports substantial equivalence to predicate device (Synthes (USA) Tibial Nail System Ex K040762). |
| Static 4-point bending test of the nail shaft (according to ASTM F1264-16 A1). | Performance supports substantial equivalence to predicate device. | |
| Torsion testing of the nail shaft (according to ASTM F1264-16 A2). | Performance supports substantial equivalence to predicate device. | |
| Dynamic 4-point bending test of the nail shaft (according to ASTM F1264-16 A3). | Performance supports substantial equivalence to predicate device. | |
| Mechanical Strength (Locking Screws) | Engineering analysis on static and cyclic 3-point bending of the locking screws (according to ASTM F1264-16 A4). | Performance supports substantial equivalence to predicate device (Synthes 4.0 and 5.0mm Locking Screws K000089). |
| Torsional properties of the locking screws (according to ASTM F543-17 A1). | Performance supports substantial equivalence to predicate device. | |
| Driving torque of the locking screws (according to ASTM F543-17 A2). | Performance supports substantial equivalence to predicate device. | |
| Driving torque and axial push-out strength of the locking screws (according to ASTM F543-17 A2 and A3). | Performance supports substantial equivalence to predicate device. | |
| Self-tapping performance of the locking screws (according to ASTM F543-17 A4). | Performance supports substantial equivalence to predicate device. | |
| MRI Safety | MRI testing in accordance with standards ASTM F2052-14, ASTM F2213-06, ASTM F2182-11a, and ASTM F2119-07. | Performance supports safety and substantial equivalence in an MRI environment. |
| Overall Conclusion | Comparison of technological characteristics, intended use, indications for use, design features, materials, and operating principle to predicate devices. Any differences do not raise new questions of safety and effectiveness; devices are at least as safe and effective. | Substantially Equivalent to predicate devices. ("The proposed devices are at least as safe and effective as the predicate devices.") |
Regarding AI/Software specific questions:
- Sample size used for the test set and the data provenance: Not applicable. This document does not describe an AI/software device or a test set of data.
- Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable. No ground truth for an AI/software test set is mentioned.
- Adjudication method for the test set: Not applicable. No adjudication for an AI/software test set is mentioned.
- If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. No AI component is described.
- If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable. No AI component is described.
- The type of ground truth used (expert consensus, pathology, outcomes data, etc): Not applicable. The "ground truth" for these devices would be established by physical measurements and engineering standards.
- The sample size for the training set: Not applicable. No AI component is described.
- How the ground truth for the training set was established: Not applicable. No AI component is described.
{0}------------------------------------------------
Build Correspondence
Image /page/0/Picture/2 description: The image contains the logos of the Department of Health and Human Services and the U.S. Food and Drug Administration (FDA). The Department of Health and Human Services logo is on the left, and the FDA logo is on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. Food & Drug Administration" in blue.
September 3, 2020
Synthes (USA) Products, LLC Pol Grebol Senior Regulatory Affairs Specialist 1301 Goshen Parkway West Chester, Pennsylvania 19380 USA
Re: K201336
Trade/Device Name: DePuy Synthes Tibial Nail Advanced System DePuy Synthes Locking Screws for Medullary Nails, 4.0 and 5.0 mm Regulation Number: 21 CFR 888.3030 Regulation Name: Single/multiple component metallic bone fixation appliances and accessories Regulatory Class: Class II Product Code: JDS, HWC Dated: July 31, 2020 Received: August 3, 2020
Dear Pol Grebol:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{1}------------------------------------------------
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-howreport-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See (https://www.fda.gov/medical-device-advice-comprehensive-regulatory-DICE website the assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
For Michael Owens Assistant Director DHT6A: Division of Joint Arthroplasty Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known) K201336
Device Name
DePuy Synthes Tibial Nail Advanced System DePuy Synthes Locking Screws for Medullary Nails, 4.0 and 5.0 mm
Indications for Use (Describe)
DePuy Synthes Tibial Nail Advanced System:
The Tibial Nail Advanced implants are intended for treatment of fractures in adolescents (12-21) in which the growth plates have fused. Specifically, the implants are indicated for:
- · Open and closed proximal and distal tibial fractures
- Open and closed tibial shaft fractures
- · Tibial malunions and nonunions
DePuy Synthes Locking Screws for Medullary Nails, 4.0 and 5.0 mm:
DePuy Synthes Locking Screws are used for the static and dynamic interlocking of femoral, humeral and tibial nails.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image shows the logo for DePuy Synthes, a company that is part of the Johnson & Johnson family of companies. The logo consists of a circular graphic to the left of the company name, which is written in a dark blue, sans-serif font. Below the company name, the text "PART OF THE Johnson-Johnson FAMILY OF COMPANIES" is written in a smaller, red font.
510(k) Summary
| Sponsor | DePuy SynthesPol Fort Grèbol1301 Goshen ParkwayWest Chester, PA 19380Phone: +41 76 371 52 69Fax: +41 32 720 71 73 |
|---|---|
| Date Prepared | May 18, 2020 |
| Proprietary Name | DePuy Synthes Tibial Nail Advanced SystemDePuy Synthes Locking Screws for Medullary Nails, 4.0 and 5.0 mm |
| Classification ProductCode | JDS - Single/multiple component metallic bone fixation appliances and accessoriesHWC - Smooth or threaded metallic bone fixation fastener |
| Device ClassificationName | Nail, Fixation, BoneScrew, Fixation, Bone |
| Regulation Number /Description | 21 CFR § 888.3030 - Single/multiple component metallic bone fixation appliancesand accessories21 CFR § 888.3040 - Smooth or threaded metallic bone fixation fastener |
| Device Classification | Class II |
| Predicate Devices | Primary Predicate Device:Synthes (USA) Tibial Nail System Ex (K040762)Additional Predicate Device:Synthes 4.0 and 5.0 mm Locking Screws (K000089)Reference Device:DePuy Synthes Femoral Recon Nail System (K172157) |
| Device Description | DePuy Synthes Tibial Nail Advanced System:The DePuy Synthes Tibial Nail Advanced System is a system comprised ofintramedullary nails, locking screws, end caps implants, as well as system-specificinsertion instruments. The Tibial Nail Advanced System is intended to be used fortemporary fixation and stabilization of tibia. This system enables three differentsurgical approaches for the insertion of the nailing implant in the tibia: suprapatellar.parapatellar, and infrapatellar. The implants are manufactured from titanium alloysand provided in a range of dimensions to match individual patient anatomy.The intramedullary nailing implants are cannulated and can be inserted over areaming rod. The nailing implants are offered in a range of proximal and distal shaft |
| diameters and lengths to accommodate patient anatomy and surgical need related tothe specific fracture patterns and locations. The nails will be manufactured fromtitanium alloy (Ti-6Al-4V) and polyetherketone (PEEK).DePuy Synthes Locking Screws for Medullary Nails, 4.0 and 5.0 mm:The DePuy Synthes Locking Screws for Medullary Nails, 4.0 and 5.0 mm have adiameter of 5 mm available in lengths ranging from 26 up to 120 mm and a diameterof 4 mm available in lengths ranging from 18 up to 80 mm. These implantabledevices are fully threaded at the shaft and are self-tapping. The locking screwsfeature either a standard screw head or a low-profile screw head. The screws aremade from titanium alloy (Ti-6Al-7Nb). | |
| Indications for Use | DePuy Synthes Tibial Nail Advanced System:The Tibial Nail Advanced implants are intended for treatment of fractures in adultsand adolescents (12-21) in which the growth plates have fused. Specifically, theimplants are indicated for:Open and closed proximal and distal tibial fractures Open and closed tibial shaft fractures Tibial malunions and nonunionsDePuy Synthes Locking Screws for Medullary Nails, 4.0 and 5.0 mm:DePuy Synthes Locking Screws are used for the static and dynamic interlocking offemoral, humeral and tibial nails.DePuy Synthes Tibial Nail Advanced System: |
| Comparison ofTechnologicalCharacteristics with thePredicate Device | Device comparison demonstrated that the DePuy Synthes Tibial Nail AdvancedSystem is substantially equivalent to the previsouly cleared Synthes (USA) TibialNail System Ex (K040762) regarding intended use, indications for use,technological characteristics (design features, material and performance) as well asoperating principle. At a high level, the subject device and predicate devices arebased on the following same technological elements:Intramedulary nailing implants to provide fracture fixation and stabilization of the tibia Nail and screw design (length, diameter, shape) Nails, locking screws, and end caps manufactured from titanium alloys Hole configurations in proximal and distal part of nail Same locking options |
| Non-clinicalPerformance Data | DePuy Synthes Locking Screws for Medullary Nails, 4.0 and 5.0 mm: |
| Device comparison demonstrated that the DePuy Synthes Locking Screws forMedullary Nails, 4.0 and 5.0 mm is substantially equivalent to the previsouly clearedSynthes 4.0 and 5.0 mm Locking Screws (K000089) regarding intended use,indications for use, technological characteristics (design features, material andperformance) as well as operating principle. At a high level, the subject device andpredicate devices are based on the following same technological elements: | |
| Stabilization of intramedullary nail-bone construct Design (length, diameter, thread profile) Manufactured from titanium alloy Used for proximally and distally locking of nail-bone construct | |
| DePuy Synthes Tibial Nail Advanced System: | |
| The following non-clinical assessments were used to characterize the subject deviceas a system: | |
| LAL testing to demonstrate that the subject device meets the 20 EU/device limitset forth in FDA guidance document "Submission and Review of SterilityInformation in Premarket Notification (510(k)) Submissions for DevicesLabeled as Sterile," dated January 21, 2016, when sterilized utilizing gammaradiation Biocompatibility assessment per FDA guidance document Use of InternationalStandard ISO 10993-1, "Biological evaluation of medical devices - Part 1:Evaluation and testing within a risk management process," dated June 16, 2016 Proximal and distal locking static torsion test of the construct according toASTM F1264-16 A2.1.7 MRI testing in accordance with standards ASTM F2052-14, ASTM F2213-06,ASTM F2182-11a, and ASTM F2119-07 | |
| Subject nailing implants were also evaluated against Synthes (USA) Tibial NailSystem Ex (K040762): | |
| Static 4-point bending test of the nail shaft according to ASTM F1264-16 A1 Torsion testing of the nail shaft according to ASTM F1264-16 A2 Dynamic 4-point bending test of the nail shaft according to ASTM-16 A3 | |
| DePuy Synthes Locking Screws for Medullary Nails, 4.0 and 5.0 mm: | |
| Subject locking screws were also evaluated against Synthes 4.0 and 5.0mm LockingScrews (K000089): | |
| Engineering analysis on static and cyclic 3-point bending of the locking screwsaccording to ASTM F1264-16 A4 | |
| Torsional properties of the locking screws according to ASTM F543-17 A1 Driving torque of the locking screws according to ASTM F543-17 A2 Driving torque and axial push out strength of the locking screws according to ASTM F543-17 A2 and A3 Self-tapping performance of the locking screws according to ASTM F543-17 A4 This information supports that the performance of the subject device is substantially equivalent to that of the predicate device. | |
| ClinicalPerformance Data | Clinical performance data was not deemed necessary for the determination of substantial equivalence. |
| The proposed devices have the same intended use their predicate devices.Additionally, the devices have similar indications for use, design principles, materials, and fundamental technology as compared to the predicate devices. | |
| Substantial Equivalence | The testing and analytical evaluation included in this submission demonstrate that:Any differences in technological characteristics of the predicate devices do not raise any new questions of safety and effectiveness The proposed devices are at least as safe and effective as the predicate devices |
| Conclusion | In conclusion, the results of non-clinical performance data demonstrate that the subject device is substantially equivalent with the predicate devices. |
{4}------------------------------------------------
Image /page/4/Picture/1 description: The image shows the logo for DePuy Synthes, a company that is part of the Johnson & Johnson family of companies. The logo consists of a circular graphic on the left and the company name on the right. The company name is in a dark blue font, and the words "PART OF THE" and "Johnson-Johnson FAMILY OF COMPANIES" are in a smaller, red font below the company name.
{5}------------------------------------------------
Image /page/5/Picture/1 description: The image shows the logo for DePuy Synthes, which is part of the Johnson & Johnson family of companies. The logo consists of a circular graphic on the left and the company name on the right. The company name is in a dark blue font, and the words "PART OF THE" and "Johnson-Johnson FAMILY OF COMPANIES" are in a smaller, red font below the company name.
{6}------------------------------------------------
Image /page/6/Picture/1 description: The image shows the logo for DePuy Synthes, a company that is part of the Johnson & Johnson family of companies. The logo consists of a circular graphic to the left of the company name. The company name is written in a dark blue font, with "DePuy" on the first line and "Synthes" on the second line. Below the company name is the text "PART OF THE Johnson & Johnson FAMILY OF COMPANIES" in a smaller, red font.
§ 888.3030 Single/multiple component metallic bone fixation appliances and accessories.
(a)
Identification. Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.